Transsynaptic complex dysfunction in the hippocampus of Alzheimer's disease patients

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Alzheimer's disease (AD) involves amyloid-β and tau pathology, synaptic dysfunction, and impaired autophagy.
• Transsynaptic complexes (neurexin-cerebellin-glutamate delta receptor) are crucial for synapse organization and plasticity.
• Mechanisms linking these factors to AD progression are not fully understood.

Purpose of the Study:

• To investigate the role of cerebellin- (Cbln-) glutamate delta receptor (GluD) transsynaptic complexes in AD.
• To examine the expression of these complexes alongside autophagy and neuroplasticity markers in human AD hippocampus.
• To identify potential therapeutic targets for AD.

Main Methods:

• Analysis of human hippocampal tissues from AD patients and controls (Braak stages 0/1, 2, 5/6).
• Quantification of transsynaptic complex components, autophagy markers (PIST, beclin-1), and neuroplasticity markers (BDNF, cofilin phosphorylation).
• Co-immunoprecipitation to assess protein-protein interactions.

Main Results:

• Decreased protein levels of Cbln1 and GluD2 were observed in AD hippocampus.
• Downregulation of autophagy markers (PIST, beclin-1) and neuroplasticity markers (BDNF) in AD.
• Evidence of interactions between transsynaptic components and autophagy pathways.
• Disrupted cofilin phosphorylation suggesting impaired trafficking.

Conclusions:

• Homeostasis of synaptic integrity signaling molecules is disrupted in the human hippocampus in both early and late AD stages.
• Reduced transsynaptic complex expression correlates with downregulated autophagy and neuroplasticity markers in AD.
• These findings highlight the interconnectedness of synaptic integrity, autophagy, and neuroplasticity in AD pathogenesis.